Signal transduction pathways play a central role in cancer development and progression by regulating various cellular processes. Dysregulation of these signaling pathways is common in cancer cells and contributes to their uncontrolled growth and survival. Targeting these aberrant signaling pathways has therefore emerged as a promising strategy to prevent cancer cell proliferation and promote therapeutic outcomes. This study highlights the critical role of signaling pathway activation and regulation in cancer biology. Furthermore, our results identified oncogenes such as PIK3CA, EGFR, AKT1, MAP2K1, AR, JAK2, and JAK1 that are involved in a variety of cellular processes and signaling pathways involved in cell growth, proliferation, survival, metabolism, and signaling. In addition, we identify suppressor proteins such as EP300, TP53, CASP8, PIK3R1, CREBBP, and PTCH1 are of interest in gene regulation, DNA repair, apoptosis, and cell signaling. It is essential to recognize that the roles of these signaling proteins can vary depending on cell type and contextual factors. This study highlights that oncogenes and suppressor proteins critically shape cancer networks and profoundly influence cancer cell behavior. In particular, key proteins identified in different types of cancer, such as TP53, KRAS, CCND1, EGFR, BIRC5, and PIK3CA, underscore their importance in promoting uncontrolled cell growth and proliferation. Continued research on these proteins and their associated signaling pathways will contribute to improved cancer diagnostic and therapeutic strategies.